The pen needles market valued at US$ 1.69 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$ 1.81 Billion in 2024 ...
Novo Nordisk’s bid to provide a once-weekly basal ... but comes after insulin icodec has already been approved in the EU, Canada, Australia, Japan, and Switzerland under the Awiqli brand name ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results